Systemic treatment of malignant gastrointestinal neuroectodermal tumour after childhood neuroblastoma
Margaret Ottaviano(University of Naples Federico II), Giovannella Palmieri(Regione Campania), Brigitta Mucci(Federico II University Hospital), Vincenzo d’Alessandro, Vincenzo Di Lauro(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Mario Giuliano(Regione Campania), Sabino De Placido, Elide Matano(Regione Campania), Rossella Lauria, Gabriella Ferraro(University of Naples Federico II), Chiara De Maddalena(Federico II University Hospital), Maria DʼArmiento(University of Naples Federico II), Marianna Tortora(Regione Campania)
Cited by 4
Related Papers
Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer
|Annals of Oncology|2021|724
A Renewable Tissue Resource of Phenotypically Stable, Biologically and Ethnically Diverse, Patient-Derived Human Breast Cancer Xenograft Models
|Cancer Research|2013|485
Taxane-Based Combinations As Adjuvant Chemotherapy of Early Breast Cancer: A Meta-Analysis of Randomized Trials
|Journal of Clinical Oncology|2007|413
Multiple clinical forms of dehydrated hereditary stomatocytosis arise from mutations in PIEZO1
|Blood|2013|322
Androgen receptor in triple negative breast cancer: A potential target for the targetless subtype
|Cancer Treatment Reviews|2018|282